Role of CD36 in membrane transport and utilization of long-chain fatty acids by different tissues
- 357 Downloads
The transmembrane glycoprotein CD36 has been identified in isolated cell studies as a putative transporter of long-chain fatty acids. To examine the physiological role of CD36, we studied FA uptake and metabolism by tissues of CD36 null mice after injection with two fatty acid analogs. Compared to controls, uptake was substantially reduced (50–80%) in heart, skeletal muscle, and adipose tissues of null mice. The reduction in uptake was associated with a large decrease in fatty acid incorporation into triglycerides, which could be accounted for by an accumulation of diacylglycerides. Thus CD36 facilitates a major fraction of fatty acid uptake by myocardial, skeletal muscle, and adipose tissues, where it is highly expressed. Its role in other tissues where its expression is low and cell-specific could not be determined in these studies.
Index EntriesCD36 FAT FA transport BMIPP IPPA heart adipose triglyceride
Unable to display preview. Download preview PDF.
- Abumrad N. A., el-Maghrabi M. R., Amri E. Z., Lopez E., and Grimaldi P. A. (1993) Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem. 268, 17,665–17,668.Google Scholar
- Balendiran G. K., Schnutgen F., Scapin G., Borchers T., Xhong N., Lim K., et al. (2000) Crystal structure and thermodynamic analysis of human brain fatty acid binding protein. J. Biol. Chem., in press.Google Scholar
- Hwang E. H., Taki J., Yasue S., Fujimoto M., Taniguchi M., Matsunari I., et al. (1998) Absent myocardial iodine-123-BMIPP uptake and platelet/monocyte CD36 deficiency. J. Nucleic Med. 39, 1681–1684.Google Scholar
- Ibrahimi A., Bonen A., Blinn W. D., Hajri T., Li X., Zhong K., Cameron R., and Abumrad N. A. (1999) Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J. Biol. Chem. 274, 26,761–26,766.CrossRefGoogle Scholar
- Yoshizumi T., Nozaki S., Fukuchi K., Yamasaki K., Fukuchi T., Maruyama T., et al. (2000) Pharmacokinetics and metabolism of 123I-BMIPP fatty acid analog in healthy and CD36-deficient subjects [In Process Citation]. J. Nucleic Med. 41, 1134–1138.Google Scholar